Delisting riskPopularity #3,846
Heron Therapeutics (HRTX)
Sells U.S. hospital injectables for postsurgical pain and nausea prevention.
$0.2893
vs last close−0.01 (−3.24%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 41 days
EPS estimate
−$0.03
Revenue estimate
$37.5M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.02$0.01−$0.02−$0.05−$0.02−$0.04−$0.03Pending
Estimate−$0.03−$0.01−$0.01−$0.01−$0.03−$0.03−$0.01−$0.03
Surprise+166.7%+200.0%−100.0%−275.1%+33.3%−33.3%−500.0%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$40.8M$38.9M$37.2M$38.2M$40.6M$34.7M$37.7MPending
Estimate$36.7M$38.3M$39.1M$39.0M$39.9M$36.7M$42.2M$37.5M
Surprise+11.2%+1.7%−4.8%−2.1%+1.8%−5.5%−10.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2026 | −$0.03 | — | — |
| Nov 2026 | −$0.03 | — | — |
| Aug 2026 | −$0.01 | −$0.03 | −500.0% |
| May 2026 | −$0.03 | −$0.04 | −33.3% |
| Feb 2026 | −$0.03 | −$0.02 | +33.3% |
| Nov 2025 | −$0.01 | −$0.05 | −275.1% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2026 | −$0.03 | — | — | $38.4M | — | — | — |
| Nov 3, 2026 | −$0.03 | — | — | $37.5M | — | — | — |
| Aug 10, 2026 | −$0.01 | −$0.03 | −500.0% | $42.2M | $37.7M | −10.7% | −31.7% |
| May 11, 2026 | −$0.03 | −$0.04 | −33.3% | $36.7M | $34.7M | −5.5% | −21.1% |
| Feb 26, 2026 | −$0.03 | −$0.02 | +33.3% | $39.9M | $40.6M | +1.8% | +11.1% |
| Nov 4, 2025 | −$0.01 | −$0.05 | −275.1% | $39.0M | $38.2M | −2.1% | −3.4% |
| Aug 8, 2025 | |||||||
| May 6, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 7, 2024 | |||||||
| Mar 12, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 23, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 10, 2021 | |||||||
| Feb 24, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 6, 2020 | |||||||
| Mar 2, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 5, 2019 | |||||||
| May 9, 2019 | |||||||
| Feb 22, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 10, 2018 | |||||||
| Feb 27, 2018 | |||||||
| Nov 6, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 10, 2017 | |||||||
| Feb 23, 2017 | |||||||
| Nov 8, 2016 | |||||||
| Aug 8, 2016 | |||||||
| May 5, 2016 | |||||||
| Feb 19, 2016 | |||||||
| Nov 6, 2015 | |||||||
| Aug 7, 2015 |